MINNEAPOLIS, Sept. 12, 2016 -- Vital Images, Inc. (Vital), a Minneapolis-based advanced medical imaging and informatics company, is pleased to announce the support of Nuance PowerScribe® 360 Reporting and PenRad™ PenLung™ Lung Screening Management system in its comprehensive Lung Screening solution. The Vitrea® CT Lung Analysis application helps clinicians standardize the diagnosis of lung nodules, while the solution’s workflow system facilitates management of lung screening treatment plans.
Nuance’s PowerScribe 360 is the market-leading speech recognition technology for radiology, providing accurate, flexible and rapid reporting that is consistent and actionable. The high-quality reports generated by PowerScribe 360 can help healthcare organizations improve both patient care and physician satisfaction, and optimize billing and reimbursement.
PenLung by PenRad is a unified software solution that helps radiology departments and imaging facilities manage patients participating in low-dose computed tomography (LDCT) lung screening programs. It collects smoking and environmental risk history through automated web and tablet calculators to manage patient eligibility and export of the lung registry for reimbursement.
“We are excited to announce the support of PowerScribe 360 and PenLung as part of our comprehensive Lung Screening solution offering to healthcare organizations,” says Jim Litterer, President and CEO of Vital. “The integration of these powerful tools with CT Lung Screening can help providers continue to improve patient outcomes by streamlining both workflow and treatment plan management.”
About Vital Images, Inc.
Vital Images, Inc., a Toshiba Medical Systems Group company, is a leading provider of diagnostic imaging and enterprise informatics solutions to help healthcare organizations deliver exceptional care while optimizing resources across multi-facility organizations. The company's solutions are scalable to meet the unique needs of hospitals and imaging centers and are accessible throughout the enterprise anytime, anywhere. For more information, visit www.vitalimages.com or join the conversation on Twitter, LinkedIn and YouTube.
Vitrea is a trademark of Vital Images, Inc.
Marks not owned by Vital Images, Inc. are the property of their respective holders.
AT VITAL IMAGES: Aaron Wangen (952) 487-9632 [email protected] www.vitalimages.com


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Washington Post Publisher Will Lewis Steps Down After Layoffs
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



